reddit.com· r/endometriosis · Reddit·· 8 days agoPickScore59
Eli Lilly invests in women's health, backing Absci's ABS-201 drug designed to treat endometriosis by modifying its underlying pathogenesis.
In brief
Eli Lilly is backing Absci's ABS-201, a generative AI-designed anti-prolactin receptor antibody for endometriosis, through a $100 million financing that includes a $40 million strategic investment from Lilly. ABS-201 is designed to block prolactin receptors to modify the underlying pathogenesis of endometriosis, and Phase II trials are expected to start in Q4 2026. The support fits Lilly's stated shift toward women's health, funded by GLP-1 profits.
Why it matters
Big pharma money is moving into endometriosis, an underserved indication, with a named candidate and Phase II date.
Source: reddit.com